SP192RITUXIMAB COMBINED WITH MODIFIED IMMUNOSUPPRESSION REGIMENS SHOWED PROMISING RESPONSE IN IDIOPATHIC MEMBRANOUS NEPHROPATHY: PRELIMINARY RESULTS FROM A SMALL CHINESE COHORT. (13th June 2019)